Cagrilintide
Cagrilintide is an investigational, long-acting amylin analog designed to treat obesity and type 2 diabetes by curbing appetite and slowing digestion. Often combined with semaglutide (as CagriSema), it shows high efficacy, with studies indicating significant weight loss (up to ~22.7%) by improving satiety and reducing calorie intake.
Verifying a batch
Match the batch code on the vial to a third-party certificate of analysis showing both purity and identity.
Search lab reports for this compound →How purity is tested →
Looking for Cagrilintide?
Join our next group buy to get verified quality at wholesale prices.
All compounds listed here are supplied for laboratory research use only and are not medicines, supplements, or products for human consumption.